Method for improving yield of magnetosomes by constructing polyploidy magnetotactic spirillum
By constructing polyploid magnetotropic helix, using DNA seamless cloning and homologous recombination technology to regulate the expression of ftsZ protein, the problems of low magnetic body yield and complex genetic modification in the existing technology are solved, and the magnetosome gene is realized The overexpression and yield of the island simplifies the operation process and promotes the application of magnetosomes in the fields of materials and medicine.
Patent Information
- Application Number
- CN202411251836.9
- Authority / Receiving Office
- CN · China
- Patent Type
- Applications(China)
- Current Assignee / Owner
- Filing Date
- 2024-09-09
- Publication Date
- 2024-11-15
AI Technical Summary
The prior art is difficult to effectively increase the yield of magnetic bodies in Magnetotropic Helix, and the system for controlling and regulating magnetic body synthesis is too complex, and it is difficult to achieve the expected results for the overexpression of individual genes. The transformation of multiple genes has certain genetic inheritance. Operation difficulty.
By constructing polyploid magnetotropic helix, the reporter gene EGFP was fused with the promoter and RBS element using DNA seamless cloning method, and combined to transform it into the plasmid. The upstream and downstream fragments of the ftsZ genome were further amplified and homologous recombined to achieve homologous recombination. The expression regulation of ftsZ protein inhibits cell division, thereby achieving overexpression of magnetosome gene islands.
Overexpression of magnetosome gene islands is achieved, removing the limitation of cell space on magnetosome yield, simplifying genetic operations, reducing time costs, and promoting the widespread application of magnetosomes in fields such as materials science and medicine.
Smart Images

Figure CN118956927A_ABST
Abstract
Description
Technical Field
[0001] The invention belongs to the technical field of genetic engineering and molecular biology, and specifically relates to a method for increasing the yield of magnetosomes by constructing polyploid magnetotactic helicobacterium. Background Art
[0002] The construction of polyploid strains is a cell modification strategy that obtains efficient microbial cell factories by regulating cell division-related genes and inhibiting normal cell division. This strategy enables biological cells to contain two sets of genomes at the same time, which can control and regulate the overexpression of genes that produce a certain product. At the same time, inhibiting cell division can regulate cell morphology, to a certain extent relieve the restrictions of cell space on the production of contents, achieve a balance between bacterial morphological changes and cell growth, and ultimately achieve the purpose of increasing production. Cell division in bacteria is a finely regulated process that requires the coordination of multiple complex systems. Cell division requires three steps: marking the division site, recruiting fission bodies, and activating cell wall synthesis to drive cell contraction. ftZ The FtsZ protein expressed by the gene is a tubulin homologue and is a key gene for localization during cell division to form the "Z ring". ftZ The expression intensity of genes can regulate cell division.
[0003] Magnetotactic Helicobacter Magnetospirollum gryphiswaldense MSR-1 is a magnetic bacterium ( Magnetotactic bacteria ) can form a kind of magnetic nanoparticles called magnetosomes in its body. It is mainly distributed in aquatic environments, mostly facultative anaerobic or microaerobic strains, which can move along the magnetic lines with magnetosomes and thus tend to the aerobic and anaerobic interface that is conducive to its survival. In magnetic bacteria, the gene fragments that control the synthesis of magnetosomes are concentrated in a region called magnetosome island (MAI) on the chromosome, which is longer than 30k bp. This region contains mamAB , feoAB1 , mamGFDC , mms6 , mamXY There are multiple operon units, such as magnetosome vesicle formation, vesicle protein sorting, magnetic crystal mineralization, and magnetosome chain assembly. Each operon plays a different role in the steps of magnetosome vesicle formation, vesicle protein sorting, magnetic crystal mineralization, and magnetosome chain assembly. Because magnetosome particles have the characteristics of uniformity, single magnetic domain, paramagnetism, and good biocompatibility, they have a wide range of due value in medicine, materials science, etc., but the yield of magnetosomes is one of the key factors limiting their wide application. At present, there are few strategies to increase the yield of magnetosomes at home and abroad, and the effect is not significant. The system for controlling and regulating magnetosome synthesis is too complicated, and it is difficult to achieve the expected results by overexpressing individual genes. The transformation of multiple genes has certain genetic manipulation difficulties. Therefore, it is urgent to develop a strategy to increase the yield of magnetosomes. Summary of the invention
[0004] In order to improve the yield of magnetotactic spirochetes magnetosomes, the invention provides a method for improving the yield of magnetotactic spirochetes magnetosomes by constructing polyploid magnetotactic spirochetes.
[0005] In order to achieve the above-mentioned invention object, the present invention adopts the following technical solutions: The present invention provides a method for increasing the yield of magnetosomes by constructing polyploid magnetotactic spirochetes. The preparation method comprises the following steps: (1) The reporter gene EGFP was fused with the promoter, RBS elements J23100 / J23110 / J23116-B0034 and J23103 / J23113 / J23109-B0033, respectively, and after purification and recovery, it was assembled into the plasmid pBBR-MCS2 by the DNA seamless cloning method to obtain the characterized plasmids pBBR-100EGFP, pBBR-110EGFP, pBBR-116EGFP, pBBR-109EGFP, pBBR-113EGFP and pBBR-103EGFP.
[0006] (2) After conjugation transformation, the characterized plasmid was introduced into MSR-1, and positive clones were obtained by PCR screening.
[0007] (3) Perform fluorescence intensity detection on the positive clones described in step (2), compare the fluorescence intensity, and determine the regulatory element with appropriate intensity.
[0008] (4) Amplification ftZ Upstream and downstream fragments of the genome ftZ Up , ftsZ Dowm, the resistance gene Cm was fused and amplified with the regulatory element, purified and recovered, and then assembled and connected to the linearized pUX-19 plasmid by the DNA seamless cloning method to obtain the recombinant plasmid pUX- ftZ UD-CmR-Terminator-Promoter-RBS.
[0009] (5) After conjugation transformation, homologous recombination double exchange, and PCR verification, polyploid strains containing both wild-type and engineered genomes were screened and obtained.
[0010] (6) The polyploid strain was activated in LAY medium and then transferred to LAY medium for culture. The OD value of the strain was measured from inoculation to 48 h of culture in the presence of vertical and horizontal magnetic fields. 565 The value of Cmag is calculated according to the formula.
[0011] (7) After the strains were cultured for 48 h, they were collected and crushed, washed with PBS, and the relatively pure magnetosomes were freeze-dried. The magnetosomes were weighed and the magnetosome yield was calculated.
[0012] Furthermore, the regulatory elements of suitable strength are obtained from the iGEM database, and their sequences are shown in SEQ ID No.1, SEQ ID No.2, SEQ ID No.3, SEQ ID No.4, SEQ ID No.5, SEQ ID No.6, SEQ ID No.7, SEQ ID No.6, and SEQ ID No.9.
[0013] Furthermore, the gene sequence ftZ Up , ftsZ Dowm, from the genome of Magnetospirillum spp.
[0014] Furthermore, the gene ftZ The nucleic acid sequence of Up is shown in SEQ ID No.10.
[0015] Furthermore, the gene ftZ The nucleic acid sequence of Dowm is shown as SEQ ID No.11.
[0016] Furthermore, the calculation formula of the Cmag value is Cmag=OD 565 (=) / OD 565 (┴).
[0017] Furthermore, the calculated Cmag value of the polyploid is 2.5.
[0018] Furthermore, under a transmission electron microscope, the polyploid strain has a longer morphology and larger cell space than the wild-type strain, and the number of magnetosomes is significantly greater than that of the wild-type strain.
[0019] Compared with the prior art, the present invention has the following advantages and beneficial effects: The present invention inserts the weak expression element "CmR-terminator-promoter-RBS" into the gene essential for chromosome division. ftZ Before, weaken ftZ The expression of magnetosomes can be inhibited, the normal division of cells can be inhibited, and the construction of polyploid dehypohelical strains can be realized. This technology can not only achieve the overexpression of the entire magnetosome gene island, but also remove the limitation of cell space on magnetosome production.
[0020] The present invention only utilizes genetic manipulation of single conjugation and homologous recombination to achieve overexpression of the entire magnetosome gene island, and at the same time provides a certain basis for exploring the synthesis of menstruation regulating genes outside the magnetosome gene island. The genetic manipulation of this technology is simpler and has lower time cost, which can remove the limitation of magnetosome production on its application and promote the wide application of magnetosomes in materials science, medicine and other fields. BRIEF DESCRIPTION OF THE DRAWINGS
[0021] Figure 1This is the plasmid map of the constructed vector pBBR-100EGFP.
[0022] Figure 2 This is the plasmid map of the constructed vector pBBR-110EGFP.
[0023] Figure 3 This is the plasmid map of the constructed vector pBBR-116EGFP.
[0024] Figure 4 This is the plasmid map of the constructed vector pBBR-109EGFP.
[0025] Figure 5 This is the plasmid map of the constructed vector pBBR-113EGFP.
[0026] Figure 6 This is the plasmid map of the constructed vector pBBR-103EGFP.
[0027] Figure 7 For the constructed vector pUX- ftZ Plasmid map of UD-CmR-terminator-promoter-RBS.
[0028] Figure 8 Nucleic acid electrophoresis diagram of PCR verification results for screening polyploid strains.
[0029] Fig. 9 It is a curve graph of the Cmag values of wild type and polyploid.
[0030] Fig.10 TEM images of wild-type and polyploid magnetotactic helicobacter strains.
[0031] Fig.11 Comparison of the concentration and quantity of magnetosomes produced by the same volume of bacterial culture of wild-type and polyploid magnetotactic spirochetes. DETAILED DESCRIPTION
[0032] The present invention is further described below in conjunction with specific embodiments, but the present invention is not limited by the embodiments.
[0033] If no specific techniques or conditions are specified in the examples, the experiments were carried out according to the techniques described in the literature in the field or according to the product instructions. If no manufacturer is specified for the reagents or instruments used, they are all conventional products that can be purchased.
[0034] Example 1: Construction of vector 1. Acquisition of genes The nucleotide sequences of promoters J23100, J23110, J23116, J23109, J23113, and J23103 obtained from the iGEM database are shown in SEQ ID No.1, SEQ ID No.2, SEQ ID No.3, SEQ ID No.4, SEQ ID No.5, and SEQ ID No.6.
[0035] The nucleotide sequences of RBS, B0033 and B0034 obtained from the iGEM database are shown as SEQ ID No.7 and SEQ ID No.8.
[0036] The nucleotide sequence of terminator B0016 obtained from the iGEM database is shown as SEQ ID No.9.
[0037] The bacteria derived from magnetotactic spirochetes ( Magnetospirillum gryphiswaldese )of ftZ Up, ftZ The Down gene, whose nucleotide sequence is shown in SEQ ID No.10 and SEQ ID No.11.
[0038] Wherein SEQ ID No.1: TTGACGGCTAGCTCAGTCCTAGGTACAGTGCTAGC Wherein SEQ ID No.2: TTTACGGCTAGCTCAGTCCTAGGTACAATGCTAGC Wherein SEQ ID No.3: TTGACAGCTAGCTCAGTCCTAGGGACTATGCTAGC Wherein SEQ ID No.4: TTTACAGCTAGCTCAGTCCTAGGGACTGTGCTAGC Wherein SEQ ID No.5: CTGATGGCTAGCTCAGTCCTAGGGATTATGCTAGC Among them, SEQ ID No.6: CTGATAGCTAGCTCAGTCCTAGGGATTATGCTAGC Wherein SEQ ID No.7: TCTAGAGTCACACAGGACTACTAG Among them, SEQ ID No. 8: TCTAGAGAAAGAGGAGAAATACTAG Among them, SEQ ID No.9: AAAAAAAAACCCCGCCCCTGACAGGGCGGGGTTTTTTTT Wherein SEQ ID No.10: TGGATTACACCATCGACGGCAACGAAGGCATCCGCGATCCGCGCGGCATGTACGGCGAGCGCCTGGGCGTGGCCATCCACGTCATTTCCGCCGCCACCGGGCCGGTGCGCAACCTGATGACCGTGGTCCATCGCTGCCATCTGGACATCGAGGCCCGCGTGGTCAGCCCCTTCGCCGCCGGTCTGGCCTGTCTGGTCGACGACGAAAAGGAACTGGGCGTCACCTGCATCGACATGGGCGGCGGCACCACCTCGATCGCCGTGTTCGTCGCCGGCCAGTTGGTGCACACCGACGTCATCCCGGTGGGCGGCCACCACGTCACCAACGACATCGCCCGCGGCCTGTCGACGCCGCTGTCTTATGCCGAACGCATGAAGACGCTGTACGGCAGCGCCATCCCGTCGCCGTCCGACGACCGCGAAATGCTGAAGGTGCCGCTGGTGGGCGAGGACGAGGACGGCGCCTCCAATCAGGTGCCGCGCTCCATGCTGATCCAGATCATCCAACCGCGGTTGGAGGAGACCCTGGAACTGGTGCGCTCGCACCTGGAGAAAAGCGGCTTCGACAAGATGGCCGGGCGCCGGGTGGTCCTCACCGGCGGCGCCAGCCAGATGCAGGGCGTGCGCGATCTGGCCGGACTGGTGCTGGACAAACAGGTCCGCCTGGGCCGTCCGGTTGGTCTGCACGGTCTGCCCGAATCCACCAACGGTCCGGCGTTTTCCACCTGCGCCGGCCTGATCCGATATGCCATGGCCCATCAGCCAGTGGCCAAAAGCGGTCGCAAAGCGATCCAAGAGCAAGAAAGTCCGGGCGGTTGGGGCCGTATCGGATCGTGGTTGAAGCGAAATTTCTAGGTTCAAAAGGCCGAAACGGCCATACAGCGCGGAGGTACCAG where SEQ ID No. 11: ATGCTTAACTTTCTTCCGGGGAACCCCCAGGATCTAAAGCCGAAAATCACCGTCATCGGGGTCGGTGGAGCCGGCGGCAACGCGGTCAACAACATGATCGCGTCGCGTCTTGAGGGCGTTGAATTTATCGTCGCCAACACCGATGCCCAGGCCATCAACCAGTCGCGCACCGAGCGTCGCGTCCAGTTGGGCACCACCGTCGCCCAGGGGTTGGGTGCCGGATCGCGTCCCGAGATCGGCCGCGCCGCCGCCGAGGAAAGCCTGGAAGAGGTGATCGGCCAGATCGCCGGCGCCAACATGGTGTTCATCACCGCCGGCATGGGCGGCGGCACCGGTTCCGGCGCCGCCCCGGTCATCGCGCGGGCCGCCCGCGACCACGGCATCCTGACCGTGGGCGTGGTGACCAAGCCGTTCCACTTCGAAGGCGCGCACCGTATGCGCACCGCCGAGGGTGCCATCGAGGAACTGTCGCAATACGTCGACACCTTGATCATCATCCCCAACCAGAACCTGTTCCGCGTCGCCACCGAACGCACCACCTTCGCCGACGCCTTCAAGATGGCCGACGACGTGCTGTATTCGGGCGTGCGCGGCGTCACCGACCTGATGATCATGCCCGGCCTGATCAATCTGGATTTCGCCGACATCCGCACCGTGATGAGCGAAATGGGCAAGGCGATGATGGGCACCGGCGAGGCCGAGGGCGACAAGCGCGCCATTGAAGCCGCCGAAGCCGCCATCTCCAACCCGCTGTTGGACGACACCTCGATGAAGGGCGCCAAGGGCGTGCTCATCAACATCACCGGCGGCATGGACATGA 2. Construction of pBBR-100EGFP, pBBR-110EGFP, pBBR-116EGFP, pBBR-109EGFP, pBBR-113EGFP and pBBR-103EGFP expression vectors Using EGFP as a template, polymerase chain reaction (PCR) was performed with primers 100F / EGFPR, 110F / EGFPR, 116F / EGFPR, 109F / EGFPR, 113F / EGFPR, and primer 103F / EGFPR to fusion-amplify 100EGFP, 110EGFP, 116EGFP, 109EGFP, 113EGFP, and 103EGFP fragments. The PCR amplification system is as follows: template 100 ng Primer 1 0.5 μM Primer 2 0.5 μM 2 × Phanta Max Master Mix (Dye Plus) DNA Polymerase (Vazyme, Cat. No. P525-01) 1 μL 2×Phanta Max Buffer 25 μL dNTP 1 μL Ultrapure water Make up to 50 μL The PCR program was: 95 °C for 3 min; 30 cycles × (95 °C for 15 s, 58 °C for 15 s, 72 °C for 4 min); 72 °C for 5 min; 16 °C ∞. The primer sequences are as follows: 100F: 5'-TTGACGGCTAGCTCAGTCCTAGGTACAGTGCTAGCTCTAGAGAAAGAGGAGAAATACTAGATGGTGAGCAAGGGCGA-3' (SEQ ID NO. 12); 110F: 5'-TTTACGGCTAGCTCAGTCCTAGGTACAATGCTAGCTCTAGAGAAAGAGGAGAAATACTAGATGGTGAGCAAGGGCGA-3' (SEQ ID NO. 13); 116F: 5'-TTGACAGCTAGCTCAGTCCTAGGGACTATGCTAGCTCTAGAGAAAGAGGAGAAATACTAGATGGTGAGCAAGGGCG-3' (SEQ ID NO. 14); 109F: 5'-TTTACAGCTAGCTCAGTCCTAGGGACTGTGCTAGCTCTAGAGTCACACAGGACTACTAGATGGTGAGCAAGGGCGAG-3' (SEQ ID NO. 15); 113F: 5'-CTGATGGCTAGCTCAGTCCTAGGGATTATGCTAGCTCTAGAGTCACACAGGACTACTAGATGGTGAGCAAGGGCGAG-3' (SEQ ID NO. 16); 103F: 5'-CTGATAGCTAGCTCAGTCCTAGGGATTATGCTAGCTCTAGAGTCACACAGGACTACTAGATGGTGAGCAAGGGCGAG-3' (SEQ ID NO. 17); EGFPR: 5'-GGCATGGACGAGCTGTACAAGTAACAATAGGCCGACTGCGATGAGT-3' (SEQ ID NO. 18).
[0039] The PCR product was purified by gel recovery and purification kit (Vazyme, catalog number DC301-01).
[0040] Using plasmid pBBR-MCS2 as a template and primers pBBR-RF / pBBR-RR, polymerase chain reaction (PCR) was performed to linearly amplify pBBR-MCS2. The PCR amplification system is as follows: template 100 ng Primer 1 0.5 μM Primer 2 0.5 μM 2 × Phanta Max Master Mix (Dye Plus) DNA Polymerase (Vazyme, Cat. No. P525-01) 1 μL 2×Phanta Max Buffer 25 μL dNTP 1 μL Ultrapure water Make up to 50 μL The PCR program was: 95 °C for 3 min; 30 cycles × (95 °C for 15 s, 58 °C for 15 s, 72 °C for 4 min); 72 °C for 5 min; 16 °C ∞. The primer sequences are as follows: Liquid collection and purification.
[0041] Using seamless cloning enzymes for fusion, the system is as follows: The fusion system was incubated at 50 °C for 1 h. E. coli DH5α competent cells were plated on LB solid plates containing 50 mg / L kanamycin, and positive clones were screened by PCR. The recombinant plasmid pBBR-100EGFP ( Figure 1 )、pBBR-110EGFP( Figure 2 )、pBBR-116EGFP( Figure 3 )、pBBR-109EGFP( Figure 4 )、pBBR-113EGFP( Figure 5 ) and pBBR-103EGFP ( Figure 6 ) and then identified by sequencing.
[0042] pUX- ftZ Construction of UD-CmR-terminator-promoter-RBS knock-in vector The genome of magnetotactic helicobacterium was used as a template, and polymerase chain reaction (PCR) was performed with primers UpF / UpR and primers DownF / DownR, respectively, to amplify ftZ Up, ftZ Down fragment, its PCR amplification system is as follows: template 100 ng Primer 1 0.5 μM Primer 2 0.5 μM 2 × Phanta Max Master Mix (Dye Plus) DNA Polymerase (Vazyme, Cat. No. P525-01) 1 μL 2×Phanta Max Buffer 25 μL dNTP 1 μL Ultrapure water Make up to 50 μL The PCR program was: 95 °C for 3 min; 30 cycles × (95 °C for 15 s, 60 °C for 15 s, 72 °C for 4 min); 72 °C for 5 min; 16 °C ∞. The primer sequences are as follows: UpF: 5'-TTAGCGCCCGCTCCTTTTCGCTTTTGGATTACACCATCGACGGCAA-3' (SEQ ID NO. 19); UpR: 5'-ACCGAACAGGCTTATGTCAACTGGTACCTCCGCGCTGTAT-3' (SEQ ID NO. 20); DownF: 5'-TCTAGAGTCACACAGGACTACTAGATGCTAACTTTCTTCCGGGGAACC-3' (SEQ ID NO. 21); DownFR: 5'-TGGCGAGAAAGGAAGGGAAGTCATGTCCATGCCGCCGGTGAT-3' (SEQ ID NO. 22).
[0043] The PCR product was purified by gel recovery and purification kit (Vazyme, catalog number DC301-01).
[0044] by Cm The fragment was used as a template, and the primers CmRF / RBSR were used for polymerase chain reaction (PCR) to fusion amplify the CmR-terminator-promoter-RBS fragment. The PCR amplification system is as follows: template 100 ng Primer 1 0.5 μM Primer 2 0.5 μM 2 × Phanta Max Master Mix (Dye Plus) DNA Polymerase (Vazyme, Cat. No. P525-01) 1 μL 2×Phanta Max Buffer 25 μL dNTP 1 μL Ultrapure water Make up to 50 μL The PCR program was: 95 °C for 3 min; 30 cycles × (95 °C for 15 s, 55 °C for 15 s, 72 °C for 4 min); 72 °C for 5 min; 16 °C ∞. The primer sequences are as follows: CmRF: 5'-ATACAGCGCGGAGGTACCAGTTGACATAAGCCTGTTCGGT-3' (SEQ ID NO. 23); RBSR: 5'-GTCCTAGGGATTATGCTAGCTCTAGAGTCACACAGGACTACTAGATGCTTAACTTTCTT-3' (SEQ ID NO. 24).
[0045] Liquid collection and purification was performed.
[0046] Using plasmid pUX-19 as a template and primers pUX-RF / pUX-RR, polymerase chain reaction (PCR) was performed to linearize and amplify pUX-19. The PCR amplification system is as follows: template 100 ng Primer 1 0.5 μM Primer 2 0.5 μM 2 × Phanta Max Master Mix (Dye Plus) DNA Polymerase (Vazyme, Cat. No. P525-01) 1 μL 2×Phanta Max Buffer 25 μL dNTP 1 μL Ultrapure water Make up to 50 μL The PCR program was: 95 °C for 3 min; 30 cycles × (95 °C for 15 s, 56 °C for 15 s, 72 °C for 4 min); 72 °C for 5 min; 16 °C ∞. The primer sequences are as follows: Liquid collection and purification.
[0047] The fragment enzyme is fused using seamless cloning, and the system is as follows: Using seamless cloning, the fragment CmR-terminator-promoter-RBS, ftZ Up, ftZ Down was cloned into the pUX-19 plasmid, and the system is as follows: The fusion system was incubated at 50 °C for 1 h. E. coli DH5α competent cells were plated on LB solid plates containing 50 mg / L chloramphenicol, and positive clones were screened by PCR. The recombinant plasmid pUX- ftZ UD-CmR-Terminator-Promoter-RBS ( Figure 7 ) and then identified by sequencing.
[0048] Example 2: Construction of polyploid strains pUX- ftZ The UD-CmR-terminator-promoter-RBS recombinant plasmid was transformed into magnetotactic spirochetes by conjugation. After homologous recombination, PCR screening was used to obtain strains containing both wild-type and engineered genomes, thereby obtaining polyploid magnetotactic spirochetes MSR-1.
[0049] Example 3: Extraction and yield determination of magnetosomes 1. Activation and cultivation of strains The correctly sequenced engineered strain MSR-1 was transferred to LAY liquid medium and cultured at 30°C to activate it to the logarithmic phase. The activated bacterial solution was transferred to LAY liquid medium at 1% and cultured for 48 h.
[0050] 2. Determination of Cmag value The OD values of the samples were measured every 6 h after the vertical and horizontal magnetic fields were applied. 565 The value of According to the formula: Cmag=OD 565 (=) / OD 565 (┴) Calculate.
[0051] 3. Transmission electron microscopy observation of wild-type and polyploid strain morphology and magnetosomes 10 μL of wild-type and polyploid bacterial liquid were taken respectively for transmission electron microscopy sample preparation. It was observed that the polyploid strain was longer in morphology than the wild-type strain, and the number of magnetosomes was significantly greater than that of the wild-type.
[0052] 4. Extraction of magnetosomes The cells were centrifuged at 8000 × g for 10 min and resuspended in PBS.
[0053] The high pressure homogenizer was used to crush the particles 4 times at 120 MPa.
[0054] Attach a magnet to the flask and allow the magnetosomes to be adsorbed and precipitated overnight. Repeat this process 8-10 times.
[0055] Finally, the solution was divided into centrifuge tubes and stored at -80 ℃.
Claims
1. A technology for increasing the yield of magnetosomes by constructing a polyploid strain, characterized in that: The following steps are involved: (1) Screening of suitable intensity control elements; (2) Plasmid ftZ Construction and introduction of UD-CmR-terminator-promoter-RBS, and verification of polyploid strains; (3) Production and yield determination of magnetosomes.
2. The screening of suitable strength control elements according to claim 1, characterized in that: The following steps are involved: (1) The reporter gene EGFP was fused with the promoter, RBS elements J23100 / J23110 / J23116-B0034 and J23103 / J23113 / J23109-B0033, respectively, and after purification and recovery, it was assembled into the plasmid pBBR-MCS2 by the DNA seamless cloning method to obtain the characterized plasmids pBBR-100EGFP, pBBR-110EGFP, pBBR-116EGFP, pBBR-109EGFP, pBBR-113EGFP and pBBR-103EGFP; (2) After conjugation transformation, the characterized plasmid was introduced into MSR-1, and positive clones were obtained by PCR screening; (3) Perform fluorescence intensity detection on the positive clones described in step (2), compare the fluorescence intensity, and determine the regulatory element with appropriate intensity.
3. The screening of suitable strength control elements according to claim 2, characterized in that: The regulatory elements are obtained from the iGEM database, and their sequences are shown in SEQ ID NO.1, SEQ ID NO.2, SEQ ID NO.3, SEQ ID NO.4, SEQ ID NO.5, SEQ ID NO.6, SEQ ID NO.7, SEQ ID NO.8, and SEQ ID NO.
9.
4. according to claim 1 described plasmid pUX- ftZ The construction and introduction of UD-CmR-terminator-promoter-RBS are characterized by: The following steps are involved: (1) Amplification ftZ Upstream and downstream fragments of the genome ftZ Up , ftsZ Dowm, the resistance gene Cm was fused and amplified with the regulatory element, purified and recovered, and then assembled and connected to the linearized pUX-19 plasmid by the DNA seamless cloning method to obtain the recombinant plasmid pUX- ftZ UD-CmR-terminator-promoter-RBS; (2) After conjugation transformation, homologous recombination double exchange, and PCR verification, polyploid strains containing both wild-type and engineered genomes were obtained.
5. The preparation method according to claim 4, characterized in that: Gene sequence ftZ Up , ftsZ Dowm, from the genome of Magnetospirillum spp.
6. The preparation method according to claim 5, characterized in that: Gene ftZ The nucleic acid sequence of Up is shown in SEQ ID No.
10.
7. The preparation method according to claim 5, characterized in that: Gene ftZ The nucleic acid sequence of Dowm is shown as SEQ ID No.
11.
8. The method for producing and determining the yield of magnetosomes according to claim 1, characterized in that: The following steps are involved: (1) The polyploid strain was activated in LAY medium, then transferred to LAY medium for culture, and the Cmag value from inoculation to 48 h of culture was measured; (2) After the strains were cultured for 48 h, they were collected and crushed, washed with PBS, and the relatively pure magnetosomes were freeze-dried. The magnetosomes were weighed and the magnetosome yield was calculated. (3) The polyploid strain and the wild-type strain were observed under transmission electron microscopy to observe and compare their morphology and the number of magnetosomes.
9. The method for determining the Cmag value according to claim 8, characterized in that: The following steps are involved: (1) Measure the OD under vertical and horizontal magnetic fields respectively. 565 The value of (2) Calculate the Cmag value according to the formula.
10. The preparation method according to claim 9, characterized in that: The Cmag value calculation formula is Cmag=OD 565 (=) / OD 565 (┴).
11. The preparation method according to claim 9, characterized in that: The highest Cmag value of the calculated polyploid was 2.
5.
12. The preparation method according to claim 9, characterized in that: The polyploid strain under transmission electron microscopy is longer in morphology and has larger cell spaces than the wild-type strain, and the number of magnetosomes is significantly greater than that of the wild-type strain.
